Cargando…

Oral adenosine-5’-triphosphate (ATP) administration increases blood flow following exercise in animals and humans

INTRODUCTION: Extracellular adenosine triphosphate (ATP) stimulates vasodilation by binding to endothelial ATP-selective P2Y2 receptors; a phenomenon, which is posited to be accelerated during exercise. Herein, we used a rat model to examine how different dosages of acute oral ATP administration aff...

Descripción completa

Detalles Bibliográficos
Autores principales: Jäger, Ralf, Roberts, Michael D, Lowery, Ryan P, Joy, Jordan M, Cruthirds, Clayton L, Lockwood, Christopher M, Rathmacher, John A, Purpura, Martin, Wilson, Jacob M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4086998/
https://www.ncbi.nlm.nih.gov/pubmed/25006331
http://dx.doi.org/10.1186/1550-2783-11-28
_version_ 1782324873936240640
author Jäger, Ralf
Roberts, Michael D
Lowery, Ryan P
Joy, Jordan M
Cruthirds, Clayton L
Lockwood, Christopher M
Rathmacher, John A
Purpura, Martin
Wilson, Jacob M
author_facet Jäger, Ralf
Roberts, Michael D
Lowery, Ryan P
Joy, Jordan M
Cruthirds, Clayton L
Lockwood, Christopher M
Rathmacher, John A
Purpura, Martin
Wilson, Jacob M
author_sort Jäger, Ralf
collection PubMed
description INTRODUCTION: Extracellular adenosine triphosphate (ATP) stimulates vasodilation by binding to endothelial ATP-selective P2Y2 receptors; a phenomenon, which is posited to be accelerated during exercise. Herein, we used a rat model to examine how different dosages of acute oral ATP administration affected the femoral blood flow response prior to, during, and after an exercise bout. In addition, we performed a single dose chronic administration pilot study in resistance trained athletes. METHODS: Animal study: Male Wistar rats were gavage-fed the body surface area, species adjusted human equivalent dose (HED) of either 100 mg (n=4), 400 mg (n=4), 1,000 mg (n=5) or 1,600 mg (n=5) of oral ATP as a disodium salt (Peak ATP®, TSI, Missoula, MT). Rats that were not gavage-fed were used as controls (CTL, n=5). Blood flow was monitored continuously: a) 60 min prior to, b) during and c) 90 min following an electrically-evoked leg-kicking exercise. Human Study: In a pilot study, 12 college-aged resistance-trained subjects were given 400 mg of ATP (Peak ATP®, TSI, Missoula, MT) daily for 12 weeks, and prior to an acute arm exercise bout at weeks 1, 4, 8, and 12. Ultrasonography-determined volumetric blood flow and vessel dilation in the brachial artery was measured at rest, at rest 30 minutes after supplementation, and then at 0, 3, and 6 minutes after the exercise. RESULTS: Animal Study: Rats fed 1,000 mg HED demonstrated significantly greater recovery blood flow (p < 0.01) and total blood flow AUC values (p < 0.05) compared to CTL rats. Specifically, blood flow was elevated in rats fed 1,000 mg HED versus CTL rats at 20 to 90 min post exercise when examining 10-min blood flow intervals (p < 0.05). When examining within-group differences relative to baseline values, rats fed the 1,000 mg and 1,600 mg HED exhibited the most robust increases in blood flow during exercise and into the recovery period. Human study: At weeks 1, 8, and 12, ATP supplementation significantly increased blood flow, along with significant elevations in brachial dilation. CONCLUSIONS: Oral ATP administration can increase post-exercise blood flow, and may be particularly effective during exercise recovery.
format Online
Article
Text
id pubmed-4086998
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40869982014-07-09 Oral adenosine-5’-triphosphate (ATP) administration increases blood flow following exercise in animals and humans Jäger, Ralf Roberts, Michael D Lowery, Ryan P Joy, Jordan M Cruthirds, Clayton L Lockwood, Christopher M Rathmacher, John A Purpura, Martin Wilson, Jacob M J Int Soc Sports Nutr Research Article INTRODUCTION: Extracellular adenosine triphosphate (ATP) stimulates vasodilation by binding to endothelial ATP-selective P2Y2 receptors; a phenomenon, which is posited to be accelerated during exercise. Herein, we used a rat model to examine how different dosages of acute oral ATP administration affected the femoral blood flow response prior to, during, and after an exercise bout. In addition, we performed a single dose chronic administration pilot study in resistance trained athletes. METHODS: Animal study: Male Wistar rats were gavage-fed the body surface area, species adjusted human equivalent dose (HED) of either 100 mg (n=4), 400 mg (n=4), 1,000 mg (n=5) or 1,600 mg (n=5) of oral ATP as a disodium salt (Peak ATP®, TSI, Missoula, MT). Rats that were not gavage-fed were used as controls (CTL, n=5). Blood flow was monitored continuously: a) 60 min prior to, b) during and c) 90 min following an electrically-evoked leg-kicking exercise. Human Study: In a pilot study, 12 college-aged resistance-trained subjects were given 400 mg of ATP (Peak ATP®, TSI, Missoula, MT) daily for 12 weeks, and prior to an acute arm exercise bout at weeks 1, 4, 8, and 12. Ultrasonography-determined volumetric blood flow and vessel dilation in the brachial artery was measured at rest, at rest 30 minutes after supplementation, and then at 0, 3, and 6 minutes after the exercise. RESULTS: Animal Study: Rats fed 1,000 mg HED demonstrated significantly greater recovery blood flow (p < 0.01) and total blood flow AUC values (p < 0.05) compared to CTL rats. Specifically, blood flow was elevated in rats fed 1,000 mg HED versus CTL rats at 20 to 90 min post exercise when examining 10-min blood flow intervals (p < 0.05). When examining within-group differences relative to baseline values, rats fed the 1,000 mg and 1,600 mg HED exhibited the most robust increases in blood flow during exercise and into the recovery period. Human study: At weeks 1, 8, and 12, ATP supplementation significantly increased blood flow, along with significant elevations in brachial dilation. CONCLUSIONS: Oral ATP administration can increase post-exercise blood flow, and may be particularly effective during exercise recovery. BioMed Central 2014-06-13 /pmc/articles/PMC4086998/ /pubmed/25006331 http://dx.doi.org/10.1186/1550-2783-11-28 Text en Copyright © 2014 Jäger et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Jäger, Ralf
Roberts, Michael D
Lowery, Ryan P
Joy, Jordan M
Cruthirds, Clayton L
Lockwood, Christopher M
Rathmacher, John A
Purpura, Martin
Wilson, Jacob M
Oral adenosine-5’-triphosphate (ATP) administration increases blood flow following exercise in animals and humans
title Oral adenosine-5’-triphosphate (ATP) administration increases blood flow following exercise in animals and humans
title_full Oral adenosine-5’-triphosphate (ATP) administration increases blood flow following exercise in animals and humans
title_fullStr Oral adenosine-5’-triphosphate (ATP) administration increases blood flow following exercise in animals and humans
title_full_unstemmed Oral adenosine-5’-triphosphate (ATP) administration increases blood flow following exercise in animals and humans
title_short Oral adenosine-5’-triphosphate (ATP) administration increases blood flow following exercise in animals and humans
title_sort oral adenosine-5’-triphosphate (atp) administration increases blood flow following exercise in animals and humans
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4086998/
https://www.ncbi.nlm.nih.gov/pubmed/25006331
http://dx.doi.org/10.1186/1550-2783-11-28
work_keys_str_mv AT jagerralf oraladenosine5triphosphateatpadministrationincreasesbloodflowfollowingexerciseinanimalsandhumans
AT robertsmichaeld oraladenosine5triphosphateatpadministrationincreasesbloodflowfollowingexerciseinanimalsandhumans
AT loweryryanp oraladenosine5triphosphateatpadministrationincreasesbloodflowfollowingexerciseinanimalsandhumans
AT joyjordanm oraladenosine5triphosphateatpadministrationincreasesbloodflowfollowingexerciseinanimalsandhumans
AT cruthirdsclaytonl oraladenosine5triphosphateatpadministrationincreasesbloodflowfollowingexerciseinanimalsandhumans
AT lockwoodchristopherm oraladenosine5triphosphateatpadministrationincreasesbloodflowfollowingexerciseinanimalsandhumans
AT rathmacherjohna oraladenosine5triphosphateatpadministrationincreasesbloodflowfollowingexerciseinanimalsandhumans
AT purpuramartin oraladenosine5triphosphateatpadministrationincreasesbloodflowfollowingexerciseinanimalsandhumans
AT wilsonjacobm oraladenosine5triphosphateatpadministrationincreasesbloodflowfollowingexerciseinanimalsandhumans